Metabolic myopathies: A clinical approach; Part I

Pediatric Neurology

Volumn 22, Issue 2, 2000, Pages 87-97

  Darras, Basil T ^a   Friedman, Neil R ^c  

^a

^b United States

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; LIPID;

GLYCOGEN METABOLISM; HUMAN; LIPID METABOLISM; MITOCHONDRIAL RESPIRATION; MUSCLE WEAKNESS; MYOGLOBINURIA; MYOPATHY; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; REVIEW;

ADULT; ALGORITHMS; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; METABOLISM, INBORN ERRORS; MUSCULAR DISEASES;

EID: 0033983730     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00133-2     Document Type: Review

References (37)

1. Tein I., DiMauro S., De Vivo D. Recurrent childhood myoglobinuria. Adv Pediatr. 37:1990;77-117.
2. Tonin P., Lewis P., Servidei S., DiMauro S. Metabolic causes of myoglobinuria. Ann Neurol. 27:1990;181-185.
3. Felig P., Wahren J. Fuel homeostasis in exercise. N Engl J Med. 293:1975;1078-1084.
4. Wahren J. Glucose turnover during exercise in man. Ann N Y Acad Sci. 301:1977;45-55.
5. Essen B. Intramuscular substrate utilization during prolonged exercise. Ann N Y Acad Sci. 301:1977;30-44.
6. DiMauro S., Tsujino S. Nonlysosomal glycogenoses. Engel A., Banker B. Myology. 1994;1554-1576 McGraw-Hill, New York.
7. DiMauro S., Tonin P., Servidei S. Metabolic myopathies. Rowland L., DiMauro S. Handbook of clinical neurology. 1992;479-526 Elsevier, Amsterdam.
8. DiMauro S., Miranda A.F., Sakoda S., et al. Metabolic myopathies. Am J Med Genet. 25:1986;635-651.
9. Lewis S., Haller R. The pathophysiology of McArdle's disease Clues to regulation in exercise and fatigue . J Appl Physiol. 61:1986;391-401.
10. 2 transport in muscle phosphofructokinase deficiency. J Appl Physiol. 70:1991;391-398.
11. Fishbein W. Myoadenylate deaminase deficiency Inherited and acquired forms . Biochem Med. 33:1985;158-169.
12. Tein I. Fatty acid oxidation and associated defects. American Academy of Neurology. Madison, WI: Omnipress, 1995:9-38.
13. Tein I. Metabolic myopathies. Semin Pediatr Neurol. 3:1996;59-98.
14. Hashimoto T. Peroxisomal and mitochondrial enzymes. Coates P., Tanaka K. Progress in clinical and biological research New developments in fatty acid oxidation . 1992;19-32 Wiley-Liss, New York.
15. Luo M.J., He X.Y., Sprecher H., Schulz H. Purification and characterization of the trifunctional beta-oxidation complex from pig heart mitochondria. Arch Biochem Biophys. 304:1993;266-271.
16. Bjorkhem I., Danielsson H. Omega- and (omega-1)-oxidation of fatty acids by rat liver microsomes. Eur J Biochem. 17:1970;450-459.
17. Krahling J.B., Gee R., Murphy P.A., Kirk J.R., Tolbert N.E. Comparison of fatty acid oxidation in mitochondria and peroxisomes from rat liver. Biochem Biophys Res Commun. 82:1978;136-141.
18. Kolvraa S., Gregersen N. Acyl-CoA Glycine n-acyltransferase: Organelle localization and affinity toward straight- and branched-chain acyl-CoA esters in rat liver . Biochem Med Metab Biol. 36:1986;98-105.
19. Roe C.R., Millington D.S., Maltby D.A., Bohan T.P., Kahler S.G., Chalmers R.A. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 19:1985;459-466.
20. Baretz B., Ramsdell H., Tanaka K. Identification of n-hexanoylglycine in urines from two patients with Jamaican vomiting sickness. Clin Chim Acta. 73:1976;199-202.
21. Millington D. New methods for the analysis of acylcarnitines and acyl-coenzyme A compounds. Gaskell S. Mass spectrometry in biomedical research. 1986;97-114 John Wiley, New York.
22. DiMauro S., De Vivo D.C. Diseases of carbohydrate, fatty acid, and mitochondrial metabolism. Siegel G.J., Agranoff B.W., Albers R.W., Molinoff P.B. Basic neurochemistry. 4th ed. 1989;647-670 Raven Press, New York.
23. Gollnick P., Piehl K., Saltin B. Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates. J Physiol (Lond). 241:1974;45-57.
24. Essen B. Glycogen depletion of different types in human skeletal muscle during intermittent and continuous exercise. Acta Physiol Scand. 103:1978;446-455.
25. Lithell H., Orlander J., Schele R., Sjodin B., Karlsson J. Changes in lipoprotein-lipase activity and lipid stores in human skeletal muscle with prolonged heavy exercise. Acta Physiol Scand. 107:1979;257-261.
26. DiMauro S., Bruno C. Glycogen storage diseases of muscle. Curr Opin Neurol. 11:1998;477-484.
27. DiMauro S., Bresolin N. Phosphorylase deficiency. Engel A., Banker B. Myology. 1986;1585-1601 McGraw-Hill, New York.
28. Bell A., Thompson G. Free fatty acid oxidation in bovine muscle in vivo Effects of cold exposure and feeding . Am J Physiol. 237:1979;E309-E315.
29. Hale D., Bennett M. Fatty acid oxidation disorders A new class of metabolic diseases . J Pediatr. 121:1992;1-11.
30. Tein I., De Vivo D.C., Bierman F., et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res. 28:1990;247-255.
31. Stanley C.A., DeLeeuw S., Coates P.M., et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol. 30:1991;709-716.
32. Vockley J. The changing face of disorders of fatty acid oxidation. [review] Mayo Clin Proc. 69:1994;249-257.
33. Tein I., DiMauro S., Rowland L. Myoglobinuria. Rowland L., DiMauro S. Handbook of clinical neurology. 1992;553-593 Elsevier, Amsterdam.
34. Griggs R., Mendell J., Miller R. Metabolic myopathies. Griggs R., Mendell J., Miller R. Evaluation and treatment of myopathies. 1995;247-293 F.A. Davis, Philadelphia.
35. Mortensen P., Gregersen N. The biological origin of ketotic dicarboxylic aciduria. II. In vivo and in vitro investigations of the β-oxidation of the C8-C16-dicarboxylic acids in unstarved, starved and diabetic rats. Biochim Biophys Acta. 710:1982;477-484.
36. Argov Z., Bank W.J., Boden B., Ro Y.I., Chance B. Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis. An in vivo study of phosphoglycerate mutase deficiency. Arch Neurol. 44:1987;614-617.
37. Matthews P.M., Allaire C., Shoubridge E.A., Karpati G., Carpenter S., Arnold D.L. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology. 41:1991;114-120.